Pseudomonas Aeruginosa Infection Market Size
Market Size in USD Bn
CAGR8.6%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 8.6% |
| Market Concentration | Medium |
| Major Players | AstraZeneca, Pfizer, Merck & Co., Novartis, Basilea Pharmaceutica and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Pseudomonas Aeruginosa Infection Market Analysis
The pseudomonas aeruginosa infection market is estimated to be valued at USD 1.41 Bn in 2025 and is expected to reach USD 2.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032. Increased investment in research and development of novel drugs and vaccines for treatment and prevention is driving the market. Growing geriatric population who are more susceptible to bacterial infections also contributes to market growth.